Interplay between inflammation and thrombosis in cardiovascular pathology

K Stark, S Massberg - Nature Reviews Cardiology, 2021 - nature.com
Thrombosis is the most feared complication of cardiovascular diseases and a main cause of
death worldwide, making it a major health-care challenge. Platelets and the coagulation …

American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism

TL Ortel, I Neumann, W Ageno, R Beyth… - Blood …, 2020 - ashpublications.org
In August 2022, these guidelines were reviewed by an expert work group convened by ASH.
Review included limited searches for new evidence and discussion of the search results …

Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update

NS Key, AA Khorana, NM Kuderer, K Bohlke… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE To conduct an update of the ASCO venous thromboembolism (VTE) guideline.
METHODS After publication of potentially practice-changing clinical trials, identified through …

Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update

NS Key, AA Khorana, NM Kuderer, K Bohlke… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE To provide updated recommendations about prophylaxis and treatment of
venous thromboembolism (VTE) in patients with cancer. METHODS PubMed and the …

Blood flow restriction exercise: considerations of methodology, application, and safety

SD Patterson, L Hughes, S Warmington, J Burr… - Frontiers in …, 2019 - frontiersin.org
The current manuscript sets out a series of guidelines for blood flow restriction exercise,
focusing on the methodology, application and safety of this mode of training. With the …

Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment

NB Abdol Razak, G Jones, M Bhandari, MC Berndt… - Cancers, 2018 - mdpi.com
Cancer-associated thrombosis is a major cause of mortality in cancer patients, the most
common type being venous thromboembolism (VTE). Several risk factors for developing …

A test in context: D-dimer

JI Weitz, JC Fredenburgh, JW Eikelboom - Journal of the American College …, 2017 - jacc.org
D-dimer is a soluble fibrin degradation product that results from ordered breakdown of
thrombi by the fibrinolytic system. Numerous studies have shown that D-dimer serves as a …

Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database

S Barco, SH Mahmoudpour, L Valerio… - The Lancet …, 2020 - thelancet.com
Background European estimates of the burden imposed by pulmonary embolism are not
available to this date. We aimed to assess pulmonary embolism-related mortality and time …

Global burden of thrombosis: epidemiologic aspects

AM Wendelboe, GE Raskob - Circulation research, 2016 - Am Heart Assoc
Thromboembolic conditions were estimated to account for 1 in 4 deaths worldwide in 2010
and are the leading cause of mortality. Thromboembolic conditions are divided into arterial …

Deep vein thrombosis and pulmonary embolism

M Di Nisio, N van Es, HR Büller - The Lancet, 2016 - thelancet.com
Deep vein thrombosis and pulmonary embolism, collectively referred to as venous
thromboembolism, constitute a major global burden of disease. The diagnostic work-up of …